Franklin India Opportunities Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

Franklin India Opportunities Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

Franklin India Opportunities Fund - Direct (G)

1.49%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

Citibank N.A. Deutsche Bank

Franklin Templeton Asset Management (India) Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

5000

9192.08

1.76

287.7905

January 1, 2013

0

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

19.16 %

22.03 %

1.49 %

14.01 %

19.35 %

7.4 %

R Janakiraman

B.E., PGDBM.

Prior to joining Franklin Templeton AMC, he had worked as investment manager for Indian Syntans Invt Pvt. Ltd., with Citicorp information Tech Ltd. and with UTI Securities Exchange Ltd.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right